EAM Investors’s Veracyte VCYT Stock Holding History

EAM Investors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-27,449	Closed	-$1.34M	–	445
2020 Q4	$1.34M	Sell	27,449 -9,865	-26%	-$457K	0.22%	218
2020 Q3	$1.21M	Buy	+37,314	New	+$1.19M	0.29%	159
2019 Q4	–	Sell	-89,456	Closed	-$2.15M	–	320
2019 Q3	$2.15M	Sell	89,456 -65,325	-42%	-$1.74M	0.57%	49
2019 Q2	$4.41M	Sell	154,781 -41,812	-21%	-$1.04M	1.08%	3
2019 Q1	$4.92M	Sell	196,593 -29,328	-13%	-$560K	1.21%	2
2018 Q4	$2.84M	Buy	225,921 +152,081	+206%	+$1.8M	0.77%	23
2018 Q3	$705K	Buy	+73,840	New	+$814K	0.1%	274
2017 Q3	–	Sell	-50,227	Closed	-$418K	–	349
2017 Q2	$418K	Sell	50,227 -17,784	-26%	-$145K	0.07%	282
2017 Q1	$624K	Buy	+68,011	New	+$556K	0.1%	270
2015 Q3	–	Sell	-148,324	Closed	-$1.65M	–	342
2015 Q2	$1.65M	Buy	+148,324	New	+$1.46M	0.19%	212

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

EAM Investors's VCYT Position: Q1 2021 in Review

EAM Investors sold out of Veracyte (VCYT) in Q1 2021, closing a stake of 27,449 shares — an estimated $1.34M sold.

EAM Investors first reported a position in VCYT in Q2 2015 and held it in 10 quarters. The position peaked at $4.92M in Q1 2019. 235 funds tracked by Wall St. Rank hold VCYT as of Q1 2021.

EAM Investors reported no remaining Veracyte position as of Q1 2021 after selling out during the quarter.
EAM Investors sold 27,449 Veracyte shares in Q1 2021, an estimated $1.34M.
EAM Investors first reported a position in Veracyte in Q2 2015 and held it in 10 quarters.
EAM Investors's Veracyte position peaked at $4.92M in Q1 2019.
235 funds tracked by Wall St. Rank held Veracyte as of Q1 2021.

Based on EAM Investors's 13F filing for Q1 2021, filed 11 May 2021.